Novel Challenges and Advances in Thoracic Surgery

Dear Colleagues

We are living in a new era in which progress has involved all branches of oncology and surgery, overturning some of the established cornerstones over the decades.

We aim to publish articles describing novel challenges and advances in thoracic surgery, from minimally invasive and robotic surgery for early or locally advanced lung cancer to more complex cases, including post-neoadjuvant (immuno or biological therapy) surgery. In this Special Issue, we aim to explore electromagnetic navigation bronchoscopy, 3D techniques, and medically innovative treatments.

Thanks to the significant advancement of technology (both in surgery and oncology), the advent of artificial intelligence, and the innovation of new drugs in the treatment of lung cancer, in the last 15 days we witnessed an important improvement in the medical care of patients affected by lung cancer, with extraordinary oncological and medical results.

Investigating all new therapeutic and surgical possibilities in the field of thoracic oncology. Evaluating the potential advantages of minimally invasive surgery, target therapy, and immunotherapy in the treatment of early and advanced lung cancer.

We encourage the submission of manuscripts that describe all novel challenges and advances in the treatment of lung cancer, both surgical and medical.

Dr. Antonio Mazzella
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.